Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / *W EXP 12/18/202
-
Total 13F shares
-
7,067,786
-
Share change
-
+1,548,655
-
Total reported value
-
$1,867,458
-
Price per share
-
$0.25
-
Number of holders
-
29
-
Value change
-
+$432,784
-
Number of buys
-
11
-
Number of sells
-
5
Institutional Holders of Translational Development Acquisition Corp. - *W EXP 12/18/202 (TDACW) as of Q2 2025
As of 30 Jun 2025,
Translational Development Acquisition Corp. - *W EXP 12/18/202 (TDACW) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,067,786 shares.
The largest 10 holders included
AQR Arbitrage LLC, Shaolin Capital Management LLC, Magnetar Financial LLC, CSS LLC/IL, Verition Fund Management LLC, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, Polar Asset Management Partners Inc., LMR Partners LLP, Hudson Bay Capital Management LP, and TENOR CAPITAL MANAGEMENT Co., L.P..
This page lists
29
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.